DOI QR코드

DOI QR Code

Changing trends in clinical characteristics and antibiotic susceptibility of Klebsiella pneumoniae bacteremia

  • Hyun, Miri (Department of Infectious Diseases, Keimyung University Dongsan Medical Center) ;
  • Noh, Chang In (Department of Infectious Diseases, Keimyung University Dongsan Medical Center) ;
  • Ryu, Seong Yeol (Department of Infectious Diseases, Keimyung University Dongsan Medical Center) ;
  • Kim, Hyun Ah (Department of Infectious Diseases, Keimyung University Dongsan Medical Center)
  • Received : 2015.08.05
  • Accepted : 2017.01.12
  • Published : 2018.05.01

Abstract

Background/Aims: Klebsiella pneumoniae is second most common organism of gram-negative bacteremia in Korea and one of the most common cause of urinary tract infection, and intra-abdominal infection. Methods: We compared clinical and microbiological characteristics about K. pneumoniae bacteremia in a tertiary hospital between 10 years. Group A is who had K. pneumoniae bacteremia at least one time from January 2004 to December 2005. Group B is from January 2012 to December 2013. We also analyzed antibiotic resistance, clinical manifestation of the K. pneumoniae bacteremia divided into community-acquired infections, healthcare associated infections, and nosocomial infections. Results: The resistance for ampicillin, aztreonam, cefazolin, and cefotaxime significantly increased compared to 10 years ago. Extended spectrum ${\beta}$-lactamase positivity surged from 4.3% to 19.6%. Ten years ago, 1st, 2nd cephalosporin, and aminoglycoside were used more as empirical antibiotics. But these days, empirical antibiotics were broad spectrum such as 3rd and 4th cephalosporin. In treatment outcome, acute kidney injury decreased from 47.5% to 28.7%, and mortality decreased from 48.9% to 33.2%. In community-acquired infections, there was similar in antimicrobial resistance and mortality. In healthcare-associated and nosocomial infections, there was significantly increasing in antibiotic resistance, decreasing in mortality, and acute kidney injury. Conclusions: In community-acquired infections, broader antibiotics were more used than 10 years ago despite of similar antimicrobial resistance. When K. pneumoniae bacteremia is suspected, we recommend to use the narrow spectrum antibiotics as initial therapy if there are no healthcare-associated risk factors, because the antibiotic resistance is similar to 10 years ago in community-acquired infections.

Keywords

References

  1. Kang CI, Kim SH, Bang JW, et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006;21:816-822. https://doi.org/10.3346/jkms.2006.21.5.816
  2. Sun HY, Chen SY, Chang SC, Pan SC, Su CP, Chen YC. Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility. Diagn Microbiol Infect Dis 2006;55:135-141. https://doi.org/10.1016/j.diagmicrobio.2006.01.004
  3. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980;68:332-343. https://doi.org/10.1016/0002-9343(80)90101-1
  4. Huh K, Kim J, Cho SY, et al. Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: a nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID). Diagn Microbiol Infect Dis 2013;76:477-482. https://doi.org/10.1016/j.diagmicrobio.2013.04.014
  5. Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea. J Infect 2007;54:578-583. https://doi.org/10.1016/j.jinf.2006.11.008
  6. Jung Y, Lee MJ, Sin HY, et al. Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea. BMC Infect Dis 2012;12:239. https://doi.org/10.1186/1471-2334-12-239
  7. Wie SH, Chang UI, Kim JD, et al. Clinical features of 141 cases of pyogenic liver abscess over a 10-year period and antibiotic sensitivity to the causative organisms. Infect Chemother 2008;40:199-206. https://doi.org/10.3947/ic.2008.40.4.199
  8. Garcia de la Torre M, Romero-Vivas J, Martinez-Beltran J, Guerrero A, Meseguer M, Bouza E. Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis 1985;7:143-150. https://doi.org/10.1093/clinids/7.2.143
  9. Jang TN, Kuo BI, Shen SH, et al. Nosocomial gram-negative bacteremia in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes. J Formos Med Assoc 1999;98:465-473.
  10. Sligl W, Taylor G, Brindley PG. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006;10:320-325. https://doi.org/10.1016/j.ijid.2005.07.003
  11. Lee JA, Kang CI, Joo EJ, et al. Clinical and microbiological characteristics of healthcare-associated infections in community-onset Klebsiella pneumoniae bacteremia. Infect Chemother 2012;44:56-61. https://doi.org/10.3947/ic.2012.44.2.56
  12. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637. https://doi.org/10.1097/CCM.0b013e31827e83af
  13. Lee JA, Kang CI, Joo EJ, et al. Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum ${\beta}$-lactamase-producing Klebsiella pneumoniae. Microb Drug Resist 2011;17:267-273. https://doi.org/10.1089/mdr.2010.0134
  14. Pirson M, Leclercq P, Jackson T, Leclercq M, Garrino M, Sion C. Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004. J Hosp Infect 2008;68:9-16. https://doi.org/10.1016/j.jhin.2007.10.006

Cited by

  1. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries vol.33, pp.3, 2018, https://doi.org/10.1128/cmr.00048-19
  2. Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011–2019 vol.9, pp.9, 2020, https://doi.org/10.3390/antibiotics9090630
  3. Trend of Antibiotic Usage for Hospitalized Community-acquired Pneumonia Cases in Korea Based on the 2010–2015 National Health Insurance Data vol.35, pp.47, 2018, https://doi.org/10.3346/jkms.2020.35.e390
  4. Current antibiotic resistance patterns of rare uropathogens: survey from Central European Urology Department 2011-2019 vol.21, pp.1, 2018, https://doi.org/10.1186/s12894-021-00821-8